Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

[Consensus on castration-resistant prostate cancer management in Spain.]

Alcaraz A, Martínez-Piñeiro L, Rodríguez A, Rubio J, Borque Á, Burgos J, Carballido J, Cózar JM, Crespo I, Esquena S, Gómez-Veiga F, López D, Miñana B, Morote J, Ribal MJ, Solsona E, Suárez JF, Unda M.

Arch Esp Urol. 2017 Nov;70(9):777-791. Spanish.

PMID:
29099380
2.

Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.

Morote J, Tabernero ÁJ, Álvarez Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, Angulo J, López FJ, de La Iglesia R, Romero J; ANAMEM Investigator Group.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):590-594. doi: 10.1016/j.ijrobp.2017.02.219. Epub 2017 Mar 6.

PMID:
28581399
3.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group.

Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20.

PMID:
28007457
4.

Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapy.

Palou-Redorta J, Solsona E, Angulo J, Fernández JM, Madero R, Unda M, Martínez-Piñeiro JA, Portillo J, Chantada V, Moyano JL.

Actas Urol Esp. 2016 Jul-Aug;40(6):370-7. doi: 10.1016/j.acuro.2015.12.009. Epub 2016 Feb 24. English, Spanish.

PMID:
26922518
5.

Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer.

Maroto P, Solsona E, Gallardo E, Mellado B, Morote J, Arranz JÁ, Gómez-Veiga F, Unda M, Climent MÁ, Alcaraz A.

Crit Rev Oncol Hematol. 2016 Apr;100:127-36. doi: 10.1016/j.critrevonc.2015.07.011. Epub 2015 Aug 1. Review.

PMID:
26363809
6.

The role of cystectomy in elderly patients - a multicentre analysis.

Izquierdo L, Peri L, Leon P, Ramírez-Backhaus M, Manning T, Alcaraz A, Roupret M, Solsona E, Rubio J, Sengupta S, Chan Y, Liodakis P, Gyomber D, Bolton D, Lawrentschuk N.

BJU Int. 2015 Oct;116 Suppl 3:73-9. doi: 10.1111/bju.13227. Epub 2015 Sep 2. Erratum in: BJU Int. 2016 Apr;117 Suppl 4:88.

7.

[Dynamic sentinel node biopsy in penile cancer. Indications, technique and results in a Spanish oncological center].

Gómez-Ferrer Á, Rubio J, Collado A, Casanova J, Domínguez J, Ramírez M, Ricós JV, Monrós JL, Dumont R, Iborra I, Solsona E.

Arch Esp Urol. 2015 Jul-Aug;68(6):524-31. Spanish.

PMID:
26179789
8.

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S, De Nunzio C, Okamura K, Kaasinen E, Solsona E, Ali-El-Dein B, Tatar CA, Inman BA, N'Dow J, Oddens JR, Babjuk M.

Eur Urol. 2016 Feb;69(2):231-44. doi: 10.1016/j.eururo.2015.05.050. Epub 2015 Jun 16. Review.

PMID:
26091833
9.

External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.

Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25. English, Spanish.

PMID:
25920992
10.

High-risk nonmuscle invasive bladder cancer.

Orsola A, Palou J, Solsona E.

Hematol Oncol Clin North Am. 2015 Apr;29(2):227-36, viii. doi: 10.1016/j.hoc.2014.10.009. Epub 2014 Dec 19. Review.

PMID:
25836931
11.

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.

Martínez-Piñeiro L, Portillo JA, Fernández JM, Zabala JA, Cadierno I, Moyano JL, Solsona E, Unda M, Beardo P, Rodríguez-Molina J, Chantada V, Palou J, Muntañola P, Alonso Dorrego JM, Pérez-Garcia FJ, Silva JM, Chesa N, Montesinos M, Ojea A, Madero R, Martínez-Piñeiro JA.

Eur Urol. 2015 Aug;68(2):256-62. doi: 10.1016/j.eururo.2015.02.040. Epub 2015 Mar 18.

PMID:
25794457
12.

Assessment and clinical factors associated with pain in patients undergoing transrectal prostate biopsy.

Gómez-Gómez E, Ramírez M, Gómez-Ferrer A, Rubio-Briones J, Iborra I, J Carrasco-Valiente, Campos JP, Ruiz-García J, Requena-Tapia MJ, Solsona E.

Actas Urol Esp. 2015 Sep;39(7):414-9. doi: 10.1016/j.acuro.2015.01.007. Epub 2015 Mar 6. English, Spanish.

PMID:
25745791
13.

The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy.

Morote J, Gómez-Caamaño A, Alvarez-Ossorio JL, Pesqueira D, Tabernero A, Gómez Veiga F, Lorente JA, Porras M, Lobato JJ, Ribal MJ, Planas J; ANAMET Investigators Group.

J Urol. 2015 Jun;193(6):1963-9. doi: 10.1016/j.juro.2014.12.086. Epub 2014 Dec 23.

PMID:
25541340
14.

Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.

Palou J, Hernández C, Solsona E, Abascal R, Burgués JP, Rioja C, Cabrera JA, Gutiérrez C, Rodríguez O, Iborra I, Herranz F, Abascal JM, Conde G, Oliva J.

BJU Int. 2015 Jul;116(1):37-43. doi: 10.1111/bju.13020. Epub 2015 Mar 25.

15.

Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial.

Solsona E, Madero R, Chantada V, Fernandez JM, Zabala JA, Portillo JA, Alonso JM, Astobieta A, Unda M, Martinez-Piñeiro L, Rabadan M, Ojea A, Rodriguez-Molina J, Beardo P, Muntañola P, Gomez M, Montesinos M, Martinez Piñeiro JA; Members of Club Urológico Español de Tratamiento Oncológico.

Eur Urol. 2015 Mar;67(3):508-16. doi: 10.1016/j.eururo.2014.09.026. Epub 2014 Oct 6.

PMID:
25301758
16.

Neuronal glycogen synthesis contributes to physiological aging.

Sinadinos C, Valles-Ortega J, Boulan L, Solsona E, Tevy MF, Marquez M, Duran J, Lopez-Iglesias C, Calbó J, Blasco E, Pumarola M, Milán M, Guinovart JJ.

Aging Cell. 2014 Oct;13(5):935-45. doi: 10.1111/acel.12254. Epub 2014 Jul 25.

17.

Bone health in patients with prostate cancer.

Miñana B, Cózar JM, Alcaraz A, Morote J, Gómez-Veiga FJ, Solsona E, Rodríguez-Antolín A, Carballido J.

Actas Urol Esp. 2014 Dec;38(10):685-93. doi: 10.1016/j.acuro.2014.05.003. Epub 2014 Jun 14. Review. English, Spanish.

PMID:
24934457
18.

Risk estimation of multiple recurrence and progression of non muscle invasive bladder carcinoma using new mathematical models.

Luján S, Santamaría C, Pontones JL, Ruiz-Cerdá JL, Trassierra M, Vera-Donoso CD, Solsona E, Jiménez-Cruz F.

Actas Urol Esp. 2014 Dec;38(10):647-54. doi: 10.1016/j.acuro.2014.04.007. Epub 2014 Jun 11. English, Spanish.

PMID:
24930059
19.

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.

Martínez-Piñeiro L, Schalken JA, Cabri P, Maisonobe P, de la Taille A; Triptocare Study Group.

BJU Int. 2014 Oct;114(4):608-16. doi: 10.1111/bju.12542. Epub 2014 Apr 4.

20.

Obligatory information that a patient diagnosed of prostate cancer and candidate for an active surveillance protocol must know.

Rubio-Briones J, Iborra I, Ramírez M, Calatrava A, Collado A, Casanova J, Domínguez-Escrig J, Gómez-Ferrer A, Ricós JV, Monrós JL, Dumont R, López-Guerrero JA, Salas D, Solsona E.

Actas Urol Esp. 2014 Nov;38(9):559-65. doi: 10.1016/j.acuro.2014.02.007. Epub 2014 Mar 11. English, Spanish.

PMID:
24636075

Supplemental Content

Loading ...
Support Center